Submitted by Anonymous (not verified) on 12 March 2025 - 16:04
Orphan designation: Serplulimab Treatment of small cell lung cancer, 20/02/2025 Positive
Source:
Orphan designation: Serplulimab Treatment of small cell lung cancer, 20/02/2025 Positive